> Detailanzeige
Abumayyaleh, Mohammad S. A.
[VerfasserIn];
Núñez Gil, Iván J.
[VerfasserIn];
Viana-LLamas, María C.
[VerfasserIn];
Raposeiras Roubin, Sergio
[VerfasserIn];
Romero, Rodolfo
[VerfasserIn];
Alfonso-Rodríguez, Emilio
[VerfasserIn];
Uribarri, Aitor
[VerfasserIn];
Feltes, Gisela
[VerfasserIn];
Becerra-Muñoz, Víctor Manuel
[VerfasserIn];
Santoro, Francesco
[VerfasserIn];
Pepe, Martino
[VerfasserIn];
Castro Mejía, Alex Fernando
[VerfasserIn];
Signes-Costa, Jaime
[VerfasserIn];
Gonzalez, Adelina
[VerfasserIn];
Marín, Francisco
[VerfasserIn];
López-País, Javier
[VerfasserIn];
Manzone, Edoardo
[VerfasserIn];
Vazquez Cancela, Olalla
[VerfasserIn];
Paeres, Carolina Espejo
[VerfasserIn];
Masjuan, Alvaro López
[VerfasserIn];
Velicki, Lazar
[VerfasserIn];
Weiß, Christel
[VerfasserIn];
Chipayo, David
[VerfasserIn];
Fernandez-Ortiz, Antonio
[VerfasserIn];
[...]
Post-COVID-19 syndrome and diabetes mellitus
: a propensity-matched analysis of the International HOPE-II COVID-19 registry
Teilen
Literatur-
verwaltung
Direktlink
Zur
Merkliste
Lösche von
Merkliste
Per Email teilen
Auf Twitter teilen
Auf Facebook teilen
Per Whatsapp teilen
- Medientyp: E-Artikel
- Titel: Post-COVID-19 syndrome and diabetes mellitus : a propensity-matched analysis of the International HOPE-II COVID-19 registry
- Beteiligte: Abumayyaleh, Mohammad S. A. [VerfasserIn]; Núñez Gil, Iván J. [VerfasserIn]; Viana-LLamas, María C. [VerfasserIn]; Raposeiras Roubin, Sergio [VerfasserIn]; Romero, Rodolfo [VerfasserIn]; Alfonso-Rodríguez, Emilio [VerfasserIn]; Uribarri, Aitor [VerfasserIn]; Feltes, Gisela [VerfasserIn]; Becerra-Muñoz, Víctor Manuel [VerfasserIn]; Santoro, Francesco [VerfasserIn]; Pepe, Martino [VerfasserIn]; Castro Mejía, Alex Fernando [VerfasserIn]; Signes-Costa, Jaime [VerfasserIn]; Gonzalez, Adelina [VerfasserIn]; Marín, Francisco [VerfasserIn]; López-País, Javier [VerfasserIn]; Manzone, Edoardo [VerfasserIn]; Vazquez Cancela, Olalla [VerfasserIn]; Paeres, Carolina Espejo [VerfasserIn]; Masjuan, Alvaro López [VerfasserIn]; Velicki, Lazar [VerfasserIn]; Weiß, Christel [VerfasserIn]; Chipayo, David [VerfasserIn]; Fernandez-Ortiz, Antonio [VerfasserIn]; El-Battrawy, Ibrahim [VerfasserIn]; Akın, Ibrahim [VerfasserIn]
- Erschienen: 16 May 2023
- Erschienen in: Frontiers in endocrinology ; 14(2023) vom: Mai, Artikel-ID 1167087, Seite 1-12
- Sprache: Englisch
- DOI: 10.3389/fendo.2023.1167087
- ISSN: 1664-2392
- Identifikator:
- Entstehung:
- Anmerkungen:
- Beschreibung: BackgroundDiabetes mellitus (DM) is one of the most frequent comorbidities in patients suffering from severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) with a higher rate of severe course of coronavirus disease (COVID-19). However, data about post-COVID-19 syndrome (PCS) in patients with DM are limited.MethodsThis multicenter, propensity score-matched study compared long-term follow-up data about cardiovascular, neuropsychiatric, respiratory, gastrointestinal, and other symptoms in 8,719 patients with DM to those without DM. The 1:1 propensity score matching (PSM) according to age and sex resulted in 1,548 matched pairs.ResultsDiabetics and nondiabetics had a mean age of 72.6 ± 12.7 years old. At follow-up, cardiovascular symptoms such as dyspnea and increased resting heart rate occurred less in patients with DM (13.2% vs. 16.4%; p = 0.01) than those without DM (2.8% vs. 5.6%; p = 0.05), respectively. The incidence of newly diagnosed arterial hypertension was slightly lower in DM patients as compared to non-DM patients (0.5% vs. 1.6%; p = 0.18). Abnormal spirometry was observed more in patients with DM than those without DM (18.8% vs. 13; p = 0.24). Paranoia was diagnosed more frequently in patients with DM than in non-DM patients at follow-up time (4% vs. 1.2%; p = 0.009). The incidence of newly diagnosed renal insufficiency was higher in patients suffering from DM as compared to patients without DM (4.8% vs. 2.6%; p = 0.09). The rate of readmission was comparable in patients with and without DM (19.7% vs. 18.3%; p = 0.61). The reinfection rate with COVID-19 was comparable in both groups (2.9% in diabetics vs. 2.3% in nondiabetics; p = 0.55). Long-term mortality was higher in DM patients than in non-DM patients (33.9% vs. 29.1%; p = 0.005).ConclusionsThe mortality rate was higher in patients with DM type II as compared to those without DM. Readmission and reinfection rates with COVID-19 were comparable in both groups. The incidence of cardiovascular symptoms was higher in patients without DM.
- Zugangsstatus: Freier Zugang